Literature DB >> 18592167

Basal-like carcinoma of the breast: further evidence of the possibility that most metaplastic carcinomas may be actually basal-like carcinomas.

Naoto Kuroda1, Nokiaki Fujishima, Kaori Inoue, Masahiko Ohara, Takashi Hirouchi, Keiko Mizuno, Yoshihiro Hayashi, Gang-Hong Lee.   

Abstract

Some investigators have previously suggested that basal-like carcinoma may consist of components of invasive ductal carcinoma, not otherwise specified, metaplastic carcinoma, and medullary carcinoma. We report here two cases of breast carcinoma showing basal cell/myoepithelial differentiation. The first case was a 58-year-old Japanese woman and the second case was a 39-year-old Japanese woman. The two tumors were composed of the proliferation of epithelial cells and/or spindle-or stellate-shaped cells on the background of mucinous materials. Additionally, chondroid matrix was observed in the metastatic lesion of the first case and the primary lesion of the second case. Immunohistochemically, epithelial neoplastic cells were positive for E-cadherin and cytokeratin CAM5.2, and epithelial and spindle-or stellate-shaped cells were positive for cytokeratins 5, 14, or 17, alpha-smooth muscle actin, S-100, and p63. Our results supply further evidence that most metaplastic carcinomas may be actually be basallike carcinomas.

Entities:  

Mesh:

Year:  2008        PMID: 18592167     DOI: 10.1007/s00795-007-0379-2

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  17 in total

1.  Prognostic relevance of basal cytokeratin expression in operable breast cancer.

Authors:  Piotr Potemski; Renata Kusinska; Cezary Watala; Elzbieta Pluciennik; Andrzej K Bednarek; Radzislaw Kordek
Journal:  Oncology       Date:  2006-01-12       Impact factor: 2.935

2.  Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers.

Authors:  Sebastian Leibl; Margit Gogg-Kammerer; Andrea Sommersacher; Helmut Denk; Farid Moinfar
Journal:  Am J Surg Pathol       Date:  2005-03       Impact factor: 6.394

3.  Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.

Authors:  Mi-Jung Kim; Jae Y Ro; Sei-Hyun Ahn; Hak Hee Kim; Sung-Bae Kim; Gyungyub Gong
Journal:  Hum Pathol       Date:  2006-07-18       Impact factor: 3.466

4.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

5.  Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation.

Authors:  Hitoshi Tsuda; Daisaku Morita; Mikihiko Kimura; Eiji Shinto; Yukiko Ohtsuka; Osamu Matsubara; Johji Inazawa; Kuniyoshi Tamaki; Hidetaka Mochizuki; Seiichi Tamai; Hoshio Hiraide
Journal:  Cancer Sci       Date:  2005-01       Impact factor: 6.716

6.  Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.

Authors:  François Bertucci; Pascal Finetti; Nathalie Cervera; Emmanuelle Charafe-Jauffret; Emilie Mamessier; José Adélaïde; Stéphane Debono; Gilles Houvenaeghel; Dominique Maraninchi; Patrice Viens; Colette Charpin; Jocelyne Jacquemier; Daniel Birnbaum
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

7.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study.

Authors:  Christos Sotiriou; Soek-Ying Neo; Lisa M McShane; Edward L Korn; Philip M Long; Amir Jazaeri; Philippe Martiat; Steve B Fox; Adrian L Harris; Edison T Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-13       Impact factor: 11.205

8.  Classification of ductal carcinoma in situ by gene expression profiling.

Authors:  Juliane Hannemann; Arno Velds; Johannes B G Halfwerk; Bas Kreike; Johannes L Peterse; Marc J van de Vijver
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

9.  Metaplastic breast carcinomas are basal-like tumours.

Authors:  J S Reis-Filho; F Milanezi; D Steele; K Savage; P T Simpson; J M Nesland; E M Pereira; S R Lakhani; F C Schmitt
Journal:  Histopathology       Date:  2006-07       Impact factor: 5.087

10.  Repeated observation of breast tumor subtypes in independent gene expression data sets.

Authors:  Therese Sorlie; Robert Tibshirani; Joel Parker; Trevor Hastie; J S Marron; Andrew Nobel; Shibing Deng; Hilde Johnsen; Robert Pesich; Stephanie Geisler; Janos Demeter; Charles M Perou; Per E Lønning; Patrick O Brown; Anne-Lise Børresen-Dale; David Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 12.779

View more
  9 in total

1.  Clinicopathologic features and outcomes of metaplastic breast carcinoma: comparison with invasive ductal carcinoma of the breast.

Authors:  Hyung Seok Park; Seho Park; Joo Hee Kim; Ju-Hyun Lee; So-Young Choi; Byeong-Woo Park; Kyong-Sik Lee
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

2.  Chronic sclerosing pyelitis with an increased number of IgG4-positive plasma cells.

Authors:  Naoto Kuroda; Shoichiro Nakamura; Katsushi Miyazaki; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Yasuharu Sato; Tadashi Yoshino
Journal:  Med Mol Morphol       Date:  2009-12-24       Impact factor: 2.309

Review 3.  Molecular morphological approach to the pathological study of development and advancement of human breast cancer.

Authors:  Takuya Moriya; Naoki Kanomata; Yuji Kozuka; Hisashi Hirakawa; Izo Kimijima; Michio Kimura; Mika Watanabe; Hironobu Sasano; Takanori Ishida; Noriaki Ohuchi; Jun-Ichi Kurebayashi; Hiroshi Sonoo
Journal:  Med Mol Morphol       Date:  2010-08-04       Impact factor: 2.309

4.  The majority of triple-negative breast cancer may correspond to basal-like carcinoma, but triple-negative breast cancer is not identical to basal-like carcinoma.

Authors:  Naoto Kuroda; Masahiko Ohara; Kaori Inoue; Keiko Mizuno; Nokiaki Fujishima; Nobumasa Hamaguchi; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2009-06-18       Impact factor: 2.309

5.  Application of immunocytochemistry to the diagnosis of primary epithelioid angiosarcoma of the lung.

Authors:  Naoto Kuroda; Nobumasa Hamaguchi; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Yoshihiro Hayashi; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2009-12-24       Impact factor: 2.309

6.  Metaplastic breast cancer: to radiate or not to radiate?

Authors:  Warren H Tseng; Steve R Martinez
Journal:  Ann Surg Oncol       Date:  2010-06-29       Impact factor: 5.344

7.  Lipid-rich histology in a basal-type immuno-profile breast carcinoma: a clinicopathological histochemical and immunohistochemical analysis of a case.

Authors:  Serena Russo; Diana Coppola; Paola Vinaccia; Antonella Siciliano; Francesca Baldassarre; Giovanni Battista; Giuseppe Pisani; Joseph Sepe; Francesco M Maiello
Journal:  Rare Tumors       Date:  2009-12-28

8.  Single Hormone Receptor-Positive Metaplastic Breast Cancer: Similar Outcome as Triple-Negative Subtype.

Authors:  Jinqian Mao; Jin Hu; Yanting Zhang; Jian Shen; Fang Dong; Ximeng Zhang; Jie Ming; Tao Huang; Xiaoqin Run
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

Review 9.  Morphological and pathological features of basal-like breast cancer.

Authors:  Gerardo Botti; Monica Cantile; Francesca Collina; Margherita Cerrone; Sabrina Sarno; Annamaria Anniciello; Maurizio Di Bonito
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.